0 XP   0   0   0

Nuvo Pharmaceuticals Inc
Buy or Sell?

Welcome Invester! I guess you are interested in Nuvo Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Nuvo Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Nuvo Pharmaceuticals Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Nuvo Pharmaceuticals Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Nuvo Pharmaceuticals Inc. The closing price on 2022-09-28 was $0.5168 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Nuvo Pharmaceuticals Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

1.1. Profitability of Nuvo Pharmaceuticals Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Nuvo Pharmaceuticals Inc generates for each $1 of revenue.

  • Above 10% is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Net Profit Margin of -9.0% means that $-0.09 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nuvo Pharmaceuticals Inc:

  • The MRQ is 87.3%. The company is making a huge profit. +2
  • The TTM is -9.0%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ87.3%TTM-9.0%+96.3%
TTM-9.0%YOY-20.4%+11.4%
TTM-9.0%5Y-10.9%+1.9%
5Y-10.9%10Y-10.9%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ87.3%0.9%+86.4%
TTM-9.0%1.1%-10.1%
YOY-20.4%1.7%-22.1%
5Y-10.9%0.8%-11.7%
10Y-10.9%1.3%-12.2%
1.1.2. Return on Assets

Shows how efficient Nuvo Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • -0.3% Return on Assets means that Nuvo Pharmaceuticals Inc generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nuvo Pharmaceuticals Inc:

  • The MRQ is 14.5%. Using its assets, the company is efficient in making profit. +1
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ14.5%TTM-0.3%+14.9%
TTM-0.3%YOY-1.5%+1.2%
TTM-0.3%5Y-0.7%+0.3%
5Y-0.7%10Y-0.7%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ14.5%0.2%+14.3%
TTM-0.3%0.2%-0.5%
YOY-1.5%0.1%-1.6%
5Y-0.7%-0.1%-0.6%
10Y-0.7%0.2%-0.9%
1.1.3. Return on Equity

Shows how efficient Nuvo Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • 207.8% Return on Equity means the company generated $2.08 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nuvo Pharmaceuticals Inc:

  • The MRQ is 207.8%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 51.9%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ207.8%TTM51.9%+155.8%
TTM51.9%YOY-146.7%+198.6%
TTM51.9%5Y-34.3%+86.2%
5Y-34.3%10Y-34.3%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ207.8%0.8%+207.0%
TTM51.9%0.6%+51.3%
YOY-146.7%0.6%-147.3%
5Y-34.3%0.1%-34.4%
10Y-34.3%0.5%-34.8%

1.2. Operating Efficiency of Nuvo Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nuvo Pharmaceuticals Inc is operating (creating products, providing services etc).

  • Measures how much profit Nuvo Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operating Margin of 29.6% means the company generated $0.30  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nuvo Pharmaceuticals Inc:

  • The MRQ is 29.6%. The company is operating very efficient. +2
  • The TTM is 15.9%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ29.6%TTM15.9%+13.7%
TTM15.9%YOY19.8%-3.9%
TTM15.9%5Y20.7%-4.7%
5Y20.7%10Y20.7%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ29.6%3.9%+25.7%
TTM15.9%2.3%+13.6%
YOY19.8%3.9%+15.9%
5Y20.7%3.6%+17.1%
10Y20.7%1.9%+18.8%
1.2.2. Operating Ratio

Measures how efficient Nuvo Pharmaceuticals Inc is keeping operating costs (creating products, providing services etc) low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 100.8% means that the operating costs are $1.01for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Nuvo Pharmaceuticals Inc:

  • The MRQ is 1.008. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.184. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.008TTM1.184-0.176
TTM1.184YOY1.136+0.048
TTM1.1845Y1.122+0.063
5Y1.12210Y1.1220.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0081.488-0.480
TTM1.1841.439-0.255
YOY1.1361.382-0.246
5Y1.1221.363-0.241
10Y1.1221.160-0.038

1.3. Liquidity of Nuvo Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nuvo Pharmaceuticals Inc is able to pay off short-term debts (debts due within 1 year) when selling its assets.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 217.1% means the company has $2.17 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Nuvo Pharmaceuticals Inc:

  • The MRQ is 2.171. The company is able to pay all its short-term debts. +1
  • The TTM is 2.072. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.171TTM2.072+0.098
TTM2.072YOY2.214-0.141
TTM2.0725Y2.186-0.114
5Y2.18610Y2.1860.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1711.884+0.287
TTM2.0721.898+0.174
YOY2.2142.092+0.122
5Y2.1862.123+0.063
10Y2.1861.833+0.353
1.3.2. Quick Ratio

Measures if Nuvo Pharmaceuticals Inc is able to pay off short-term debts (debts due within 1 year). But only using the most liquid assets (assets that can be quickly converted to cash).

  • Above 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean)
  • A Quick Ratio of 42.3% means the company can pay off $0.42 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nuvo Pharmaceuticals Inc:

  • The MRQ is 0.423. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.434. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.423TTM0.434-0.010
TTM0.434YOY0.460-0.026
TTM0.4345Y0.543-0.110
5Y0.54310Y0.5430.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4230.636-0.213
TTM0.4340.780-0.346
YOY0.4600.805-0.345
5Y0.5430.833-0.290
10Y0.5430.824-0.281

1.4. Solvency of Nuvo Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nuvo Pharmaceuticals Inc assets are financed with debt

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Asset Ratio of 0.93 means that Nuvo Pharmaceuticals Inc assets are financed with 93.0% credit (debt) and the remaining percentage (100% - 93.0%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Nuvo Pharmaceuticals Inc:

  • The MRQ is 0.930. The company is just able to pay all its debts by selling its assets.
  • The TTM is 1.033. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ0.930TTM1.033-0.103
TTM1.033YOY0.912+0.121
TTM1.0335Y0.942+0.091
5Y0.94210Y0.9420.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9300.429+0.501
TTM1.0330.413+0.620
YOY0.9120.391+0.521
5Y0.9420.393+0.549
10Y0.9420.397+0.545
1.4.2. Debt to Equity Ratio

Measures if Nuvo Pharmaceuticals Inc is able to pay off its debts by using shareholders equity (total assets - total liabilities).

  • Below 2 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Equity ratio of 1,329.5% means that company has $13.30 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nuvo Pharmaceuticals Inc:

  • The MRQ is 13.295. The company is just not able to pay all its debts with equity. -1
  • The TTM is 3.324. The company is just not able to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ13.295TTM3.324+9.972
TTM3.324YOY19.804-16.480
TTM3.3245Y10.110-6.787
5Y10.11010Y10.1100.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ13.2950.696+12.599
TTM3.3240.678+2.646
YOY19.8040.624+19.180
5Y10.1100.681+9.429
10Y10.1100.691+9.419

2. Market Valuation of Nuvo Pharmaceuticals Inc

2. Earnings
2.1. Price to Earnings Ratio
  • Compares the company's stock price to its earnings.
  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 15 means the investor is paying $15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nuvo Pharmaceuticals Inc:

  • The EOD is -1.931. Company is losing money. -2
  • The MRQ is -1.793. Company is losing money. -2
  • The TTM is -0.959. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-1.931MRQ-1.793-0.137
MRQ-1.793TTM-0.959-0.835
TTM-0.959YOY-1.254+0.295
TTM-0.9595Y-0.805-0.154
5Y-0.80510Y-0.8050.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-1.9310.331-2.262
MRQ-1.7930.392-2.185
TTM-0.9591.363-2.322
YOY-1.2543.640-4.894
5Y-0.8056.176-6.981
10Y-0.8056.668-7.473
2.2. Price Earnings to Growth Ratio
  • Measures how expensive or cheap the stock is compared to its predicted growth
  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Nuvo Pharmaceuticals Inc:

  • The MRQ is 0.027. Very good. +2
  • The TTM is 0.013. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.027TTM0.013+0.014
TTM0.0135Y0.0130.000
5Y0.01310Y0.0130.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0270.003+0.024
TTM0.0130.019-0.006
5Y0.0130.025-0.012
10Y0.0130.026-0.013

2. Books
2.3. Price to Book Ratio
  • Shows if the stock is under or overvalued compared to it's book value (total assets - total liabilities).
  • At or below 1 is considered healthy
  • A PB ratio of 3 means the investor is paying $3 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Nuvo Pharmaceuticals Inc:

  • The EOD is 0.669. Very good. +2
  • The MRQ is 0.621. Very good. +2
  • The TTM is -1.046. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD0.669MRQ0.621+0.048
MRQ0.621TTM-1.046+1.668
TTM-1.046YOY1.816-2.862
TTM-1.0465Y0.340-1.387
5Y0.34010Y0.3400.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD0.6691.392-0.723
MRQ0.6211.617-0.996
TTM-1.0462.042-3.088
YOY1.8162.268-0.452
5Y0.3401.997-1.657
10Y0.3401.517-1.177

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Nuvo Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.773-0.386+150%1.178-34%0.829-7%0.829-7%
Current Ratio--2.1712.072+5%2.214-2%2.186-1%2.186-1%
Debt To Asset Ratio--0.9301.033-10%0.912+2%0.942-1%0.942-1%
Debt To Equity Ratio--13.2953.324+300%19.804-33%10.110+32%10.110+32%
Eps--1.605-0.067+104%-0.204+113%-0.132+108%-0.132+108%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.873-0.090+110%-0.204+123%-0.109+112%-0.109+112%
Operating Margin--0.2960.159+86%0.198+49%0.207+43%0.207+43%
Operating Ratio--1.0081.184-15%1.136-11%1.122-10%1.122-10%
Pb Ratio0.669+7%0.621-1.046+268%1.816-66%0.340+82%0.340+82%
Pe Ratio-1.931-8%-1.793-0.959-47%-1.254-30%-0.805-55%-0.805-55%
Peg Ratio--0.0270.013+108%--0.013+108%0.013+108%
Price Per Share0.517+7%0.4800.985-51%0.924-48%0.812-41%0.812-41%
Quick Ratio--0.4230.434-2%0.460-8%0.543-22%0.543-22%
Return On Assets--0.145-0.003+102%-0.015+111%-0.007+104%-0.007+104%
Return On Equity--2.0780.519+300%-1.467+171%-0.343+116%-0.343+116%
 EOD+1 -2MRQTTM+11 -4YOY+10 -45Y+9 -610Y+9 -6

3.2. Fundamental Score

Let's check the fundamental score of Nuvo Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.931
Price to Book Ratio (EOD)Between0-10.669
Net Profit Margin (MRQ)Greater than00.873
Operating Margin (MRQ)Greater than00.296
Quick Ratio (MRQ)Greater than10.423
Current Ratio (MRQ)Greater than12.171
Debt to Asset Ratio (MRQ)Less than10.930
Debt to Equity Ratio (MRQ)Less than113.295
Return on Equity (MRQ)Greater than0.152.078
Return on Assets (MRQ)Greater than0.050.145
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Nuvo Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.224
Ma 20Greater thanMa 500.584
Ma 50Greater thanMa 1000.572
Ma 100Greater thanMa 2000.590
OpenGreater thanClose0.551
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets125,800
Total Liabilities117,000
Total Stockholder Equity8,800
 As reported
Total Liabilities 117,000
Total Stockholder Equity+ 8,800
Total Assets = 125,800

Assets

Total Assets125,800
Total Current Assets50,277
Long-term Assets50,277
Total Current Assets
Cash And Cash Equivalents 28,581
Net Receivables 9,803
Inventory 9,495
Other Current Assets 2,398
Total Current Assets  (as reported)50,277
Total Current Assets  (calculated)50,277
+/-0
Long-term Assets
Property Plant Equipment 3,851
Goodwill 13,451
Intangible Assets 58,221
Long-term Assets  (as reported)75,523
Long-term Assets  (calculated)75,523
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities23,163
Long-term Liabilities93,837
Total Stockholder Equity8,800
Total Current Liabilities
Short Long Term Debt 12,203
Accounts payable 10,339
Other Current Liabilities 274
Total Current Liabilities  (as reported)23,163
Total Current Liabilities  (calculated)22,816
+/- 347
Long-term Liabilities
Long term Debt 81,280
Other Liabilities 11,397
Long-term Liabilities Other 1,223
Long-term Liabilities  (as reported)93,837
Long-term Liabilities  (calculated)93,900
+/- 63
Total Stockholder Equity
Common Stock184,764
Retained Earnings -192,482
Other Stockholders Equity 45
Total Stockholder Equity (as reported)8,800
Total Stockholder Equity (calculated)-7,673
+/- 16,473
Other
Capital Stock184,764
Common Stock Shares Outstanding 11,388
Net Debt 64,902
Net Invested Capital 102,283
Net Tangible Assets -62,872
Net Working Capital 27,114



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
> Total Assets 
163,091
167,780
158,323
156,150
151,765
149,724
150,063
135,040
130,329
127,376
125,800
125,800127,376130,329135,040150,063149,724151,765156,150158,323167,780163,091
   > Total Current Assets 
47,218
46,350
41,620
42,471
43,735
44,470
47,249
50,042
50,698
49,953
50,277
50,27749,95350,69850,04247,24944,47043,73542,47141,62046,35047,218
       Cash And Cash Equivalents 
23,019
16,300
17,157
21,108
23,807
23,752
27,265
28,410
30,874
26,545
28,581
28,58126,54530,87428,41027,26523,75223,80721,10817,15716,30023,019
       Net Receivables 
15,067
18,833
12,910
10,286
8,112
8,837
8,980
11,002
9,235
12,062
9,803
9,80312,0629,23511,0028,9808,8378,11210,28612,91018,83315,067
       Inventory 
7,927
8,694
8,814
8,607
9,490
10,932
8,761
8,621
8,534
9,179
9,495
9,4959,1798,5348,6218,76110,9329,4908,6078,8148,6947,927
   > Long-term Assets 
115,873
121,430
116,703
113,679
108,030
105,254
102,814
84,998
79,631
77,423
75,523
75,52377,42379,63184,998102,814105,254108,030113,679116,703121,430115,873
       Property Plant Equipment 
4,423
4,608
4,465
4,232
4,505
4,452
4,299
4,152
4,103
3,961
3,851
3,8513,9614,1034,1524,2994,4524,5054,2324,4654,6084,423
       Goodwill 
27,580
28,563
28,148
27,969
27,445
27,355
27,275
14,631
13,627
13,526
13,451
13,45113,52613,62714,63127,27527,35527,44527,96928,14828,56327,580
       Intangible Assets 
83,558
85,335
81,538
78,931
73,486
70,945
68,858
66,072
61,901
59,936
58,221
58,22159,93661,90166,07268,85870,94573,48678,93181,53885,33583,558
       Other Assets 
312
2,924
2,552
2,547
2,594
2,502
2,382
143
0
0
0
0001432,3822,5022,5942,5472,5522,924312
> Total Liabilities 
138,999
144,858
137,536
137,647
131,403
146,995
138,017
140,955
141,722
136,446
117,000
117,000136,446141,722140,955138,017146,995131,403137,647137,536144,858138,999
   > Total Current Liabilities 
28,443
18,048
15,565
15,014
21,756
22,616
23,061
22,885
25,190
26,016
23,163
23,16326,01625,19022,88523,06122,61621,75615,01415,56518,04828,443
       Short Long Term Debt 
18,385
5,481
6,568
6,342
12,337
11,910
11,737
12,067
12,340
11,836
12,203
12,20311,83612,34012,06711,73711,91012,3376,3426,5685,48118,385
       Accounts payable 
6,478
9,519
6,989
7,172
5,114
9,676
10,073
9,247
11,352
12,465
10,339
10,33912,46511,3529,24710,0739,6765,1147,1726,9899,5196,478
       Other Current Liabilities 
130
2,909
1,840
1,303
921
805
1,051
1,371
1,134
1,344
274
2741,3441,1341,3711,0518059211,3031,8402,909130
   > Long-term Liabilities 
110,556
126,810
121,971
122,633
109,647
124,379
114,956
118,070
116,532
110,430
93,837
93,837110,430116,532118,070114,956124,379109,647122,633121,971126,810110,556
       Long term Debt 
104,992
117,165
109,602
105,118
91,360
88,464
85,566
85,818
83,370
80,526
81,280
81,28080,52683,37085,81885,56688,46491,360105,118109,602117,165104,992
       Other Liabilities 
5,220
8,739
11,492
16,667
17,006
34,651
28,119
31,000
31,955
28,721
11,397
11,39728,72131,95531,00028,11934,65117,00616,66711,4928,7395,220
       Long-term Liabilities Other 
3,036
4,596
3,815
3,888
4,323
3,413
2,857
1,873
1,301
1,255
1,223
1,2231,2551,3011,8732,8573,4134,3233,8883,8154,5963,036
> Total Stockholder Equity
24,092
22,922
20,787
18,503
20,362
2,729
12,046
-5,915
-11,393
-9,070
8,800
8,800-9,070-11,393-5,91512,0462,72920,36218,50320,78722,92224,092
   Common Stock
184,764
184,764
184,764
184,764
184,764
184,764
184,764
184,764
184,764
184,764
184,764
184,764184,764184,764184,764184,764184,764184,764184,764184,764184,764184,764
   Retained Earnings -192,482-210,764-212,797-207,204-189,434-198,581-180,592-183,029-180,197-173,418-176,501
   Accumulated Other Comprehensive Income 00000000000
   Capital Surplus 00000000000
   Treasury Stock00000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue68,907
Cost of Revenue-24,396
Gross Profit44,51144,511
 
Operating Income (+$)
Gross Profit44,511
Operating Expense-55,692
Operating Income13,215-11,181
 
Operating Expense (+$)
Research Development-
Selling General Administrative23,868
Selling And Marketing Expenses-
Operating Expense55,69223,868
 
Net Interest Income (+$)
Interest Income150
Interest Expense-10,253
Net Interest Income-10,103-10,103
 
Pretax Income (+$)
Operating Income13,215
Net Interest Income-10,103
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-29,34745,674
EBIT - interestExpense = 2,704
-29,347
-21,952
Interest Expense10,253
Earnings Before Interest and Taxes (ebit)12,957-19,094
Earnings Before Interest and Taxes (ebitda)-11,044
 
After tax Income (+$)
Income Before Tax-29,347
Tax Provision-2,858
Net Income From Continuing Ops-32,205-32,205
Net Income-32,205
Net Income Applicable To Common Shares-32,205
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-32,45910,103
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ASCC.PINK
now

I found you a MACD Bearish Reversal Divergence on the daily chart of ASCC.PINK.

ASCC.PINK Daily Candlestick Chart
X.TO
4 minutes ago

I found you a Death Cross on the daily chart of X.TO.

X.TO Daily Candlestick Chart
VQS.TO
6 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VQS.TO.

VQS.TO Daily Candlestick Chart
VHI.TO
6 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VHI.TO.

VHI.TO Daily Candlestick Chart
VET.TO
6 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of VET.TO.

VET.TO Daily Candlestick Chart
TOT.TO
6 minutes ago

I found you a Death Cross on the daily chart of TOT.TO.

TOT.TO Daily Candlestick Chart
BES.V
8 minutes ago

I found you a Three Black Crows Candle Pattern on the daily chart of BES.V.

BES.V Daily Candlestick Chart
VOPKY.PINK
9 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOPKY.PINK.

VOPKY.PINK Daily Candlestick Chart
TTNDY.PINK
9 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TTNDY.PINK.

TTNDY.PINK Daily Candlestick Chart
PRN.TO
10 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PRN.TO.

PRN.TO Daily Candlestick Chart
PWM.V
10 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PWM.V.

PWM.V Daily Candlestick Chart
MOZ.TO
12 minutes ago

I found you a RSI Bearish Hidden Divergence on the daily chart of MOZ.TO.

MOZ.TO Daily Candlestick Chart
LUM.V
15 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LUM.V.

LUM.V Daily Candlestick Chart
LIO.V
15 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of LIO.V.

LIO.V Daily Candlestick Chart
IPO.TO
16 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of IPO.TO.

IPO.TO Daily Candlestick Chart
TNZ.TO
19 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TNZ.TO.

TNZ.TO Daily Candlestick Chart
EXE.TO
20 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EXE.TO.

EXE.TO Daily Candlestick Chart
ESI.TO
20 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of ESI.TO.

ESI.TO Daily Candlestick Chart
CWEB.TO
22 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of CWEB.TO.

CWEB.TO Daily Candlestick Chart
USO.MX
26 minutes ago

I found you a Death Cross on the daily chart of USO.MX.

USO.MX Daily Candlestick Chart
ATMS.PINK
26 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ATMS.PINK.

ATMS.PINK Daily Candlestick Chart
CTM.V
26 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CTM.V.

CTM.V Daily Candlestick Chart
USLG.PINK
32 minutes ago

I found you a Death Cross on the daily chart of USLG.PINK.

USLG.PINK Daily Candlestick Chart
FTWIJPNC.INDX
36 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of FTWIJPNC.INDX.

FTWIJPNC.INDX Daily Candlestick Chart
0IZ8.IL
37 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 0IZ8.IL.

0IZ8.IL Daily Candlestick Chart